Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Olive compound could ease pregnancy hypertension

NCT ID NCT07298759

Disease control Sponsor: Dr Cipto Mangunkusumo General Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Aug 27, 2026 · Updated 3 times

Summary

This study tests whether hydroxytyrosol, a natural antioxidant from olives, can improve blood vessel function in pregnant women with high blood pressure. Fifty-two women will take either the supplement or a placebo for 4 weeks. Researchers will measure changes in blood markers and ultrasound scans of the uterine and arm arteries.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Hydroxytyrosol (a natural compound from olives)
What this could lead to
If it works, this could point toward a simple supplement to help manage blood pressure and blood vessel health during pregnancy.
What could go wrong
This is a small, early-phase trial with only 52 participants. The results may not be strong enough to change practice, and the supplement may not show clear benefits over placebo.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

52 people

The number who actually took part.

Started

Jun 2025

Finished

Feb 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

Children (under 18), adults (18 to 64) and older adults (65 and over)

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Singleton pregnancy with a live intrauterine fetus 2. Gestational age 24-32 weeks. Gestational age is confirmed based on: * Last Menstrual Period (LMP) * First trimester ultrasound biometry 3. Belongs to the Hypertensive Disorders of Pregnancy group, with the following criteria: * Gestational hypertension and preeclampsia according to ACOG 2018 criteria * Chronic hypertension according to ACOG 2019 criteria * Superimposed preeclampsia according to ACOG 2018 criteria Exclusion Criteria: 1. Pregnancy with infection, including chronic infections such as tuberculosis (TB), HIV, or hepatitis B 2. Pregnancy with other complications (e.g., diabetes mellitus, heart disease, kidney disease, liver disease, malignancy, autoimmune disorders) 3. Refusal to participate in the study

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Chronic hypertension are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

hypertension, pregnancy-induced hypertensive disorder preeclampsia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Hypertension in pregnancy

Contacts and locations

Locations

  • Dr. Cipto Mangunkusumo National Central Public Hospital

    Jakarta, Jakarta Special Capital Region, 10430, Indonesia

More trials for these conditions

Other studies related to the condition(s) this trial covers.